99 related articles for article (PubMed ID: 2058267)
1. Adjuvant activity of non-ionic block copolymers. IV. Effect of molecular weight and formulation on titre and isotype of antibody.
Hunter R; Olsen M; Buynitzky S
Vaccine; 1991 Apr; 9(4):250-6. PubMed ID: 2058267
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant activity of non-ionic block copolymers. V. Modulation of antibody isotype by lipopolysaccharides, lipid A and precursors.
Takayama K; Olsen M; Datta P; Hunter RL
Vaccine; 1991 Apr; 9(4):257-65. PubMed ID: 2058268
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of Streptococcus pneumoniae type 14 capsular polysaccharide: influence of carriers and adjuvants on isotype distribution.
van de Wijgert JH; Verheul AF; Snippe H; Check IJ; Hunter RL
Infect Immun; 1991 Aug; 59(8):2750-7. PubMed ID: 1855991
[TBL] [Abstract][Full Text] [Related]
4. The adjuvant activity of nonionic block polymer surfactants. II. Antibody formation and inflammation related to the structure of triblock and octablock copolymers.
Hunter RL; Bennett B
J Immunol; 1984 Dec; 133(6):3167-75. PubMed ID: 6491284
[TBL] [Abstract][Full Text] [Related]
5. Humoral immunity in the ewe. 1. The influence of adjuvancy and immunogenic substitution on immune reactivity following immunisation with protein antigens.
Reynolds GE; Suttie J; Griffin JF
Vet Immunol Immunopathol; 1990 May; 25(1):1-12. PubMed ID: 2190411
[TBL] [Abstract][Full Text] [Related]
6. Comparison of conventional adjuvants and 'adjuvant-free' monoclonal antibody targeting for stimulating antibody responses against a conjugate of luteinizing hormone releasing hormone and avidin.
Tiong GK; Gill HS; Lofthouse S; Puri NK
Vaccine; 1993; 11(4):425-30. PubMed ID: 8470426
[TBL] [Abstract][Full Text] [Related]
7. Development of an adjuvant-active nonionic block copolymer for use in oil-free subunit vaccines formulations.
Todd CW; Pozzi LA; Guarnaccia JR; Balasubramanian M; Henk WG; Younger LE; Newman MJ
Vaccine; 1997 Apr; 15(5):564-70. PubMed ID: 9160526
[TBL] [Abstract][Full Text] [Related]
8. The control of the antibody isotype response to recombinant human immunodeficiency virus gp120 antigen by adjuvants.
Bomford R; Stapleton M; Winsor S; McKnight A; Andronova T
AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1765-71. PubMed ID: 1457190
[TBL] [Abstract][Full Text] [Related]
9. Murine IgG isotype responses to the Plasmodium cynomolgi circumsporozoite peptide (NAGG)5. I. Effects of carrier, copolymer adjuvants, and lipopolysaccharide on isotype selection.
Kalish ML; Check IJ; Hunter RL
J Immunol; 1991 May; 146(10):3583-90. PubMed ID: 2026882
[TBL] [Abstract][Full Text] [Related]
10. Influenza virus neutralizing antibodies and IgG isotype profiles after immunization of mice with influenza A subunit vaccine using various adjuvants.
Benne CA; Harmsen M; van der Graaff W; Verheul AF; Snippe H; Kraaijeveld CA
Vaccine; 1997 Jun; 15(9):1039-44. PubMed ID: 9261954
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant effects of nonionic block polymer surfactants on liposome-induced humoral immune response.
Zigterman GJ; Snippe H; Jansze M; Willers JM
J Immunol; 1987 Jan; 138(1):220-5. PubMed ID: 3782798
[TBL] [Abstract][Full Text] [Related]
12. Role of adjuvants in the modulation of antibody isotype, specificity, and induction of protection by whole blood-stage Plasmodium yoelii vaccines.
ten Hagen TL; Sulzer AJ; Kidd MR; Lal AA; Hunter RL
J Immunol; 1993 Dec; 151(12):7077-85. PubMed ID: 8258712
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant effects of dimethyl dioctadecyl ammonium bromide, complete Freund's adjuvant and aluminium hydroxide on neutralizing antibody, antibody-isotype and delayed-type hypersensitivity responses to Semliki Forest virus in mice.
Katz D; Lehrer S; Galan O; Lachmi BE; Cohen S
FEMS Microbiol Immunol; 1991 Nov; 3(6):305-20. PubMed ID: 1812932
[TBL] [Abstract][Full Text] [Related]
14. Development of adjuvant-active nonionic block copolymers.
Todd CW; Balusubramanian M; Newman MJ
Adv Drug Deliv Rev; 1998 Jul; 32(3):199-223. PubMed ID: 10837645
[TBL] [Abstract][Full Text] [Related]
15. Isotype profiles induced in Balb/c mice during foot and mouth disease (FMD) virus infection or immunization with different FMD vaccine formulations.
Pérez Filgueira DM; Berinstein A; Smitsaart E; Borca MV; Sadir AM
Vaccine; 1995 Jul; 13(10):953-60. PubMed ID: 7483770
[TBL] [Abstract][Full Text] [Related]
16. Enhanced antibody response to liposome-associated protein antigens: preferential stimulation of IgG2a/b production.
Phillips NC; Emili A
Vaccine; 1992; 10(3):151-8. PubMed ID: 1557930
[TBL] [Abstract][Full Text] [Related]
17. Increased adjuvant efficacy in stimulation of antibody responses after macrophage elimination in vivo.
Leenaars PP; Savelkoul HF; Hendriksen CF; Van Rooijen N; Claassen E
Immunology; 1997 Mar; 90(3):337-43. PubMed ID: 9155638
[TBL] [Abstract][Full Text] [Related]
18. Ion transport mediated by copolymers composed of polyoxyethylene and polyoxypropylene.
Atkinson TP; Bullock JO; Smith TF; Mullins RE; Hunter RL
Am J Physiol; 1988 Jan; 254(1 Pt 1):C20-6. PubMed ID: 3337217
[TBL] [Abstract][Full Text] [Related]
19. Impaired stimulation of anti-bovine serum albumin IgG antibodies by vaccine adjuvants in murine acquired immunodeficiency syndrome.
Phillips NC
FEMS Microbiol Immunol; 1992 Apr; 4(4):209-18. PubMed ID: 1599706
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of HIV type 1 vaccine immunogenicity by block copolymer adjuvants. I. Induction of high-titer, long-lasting, cross-reactive antibodies of broad isotype.
McNicholl JM; Bond KB; Ruhadze ER; Olsen MR; Takayama K; Hunter RL
AIDS Res Hum Retroviruses; 1998 Nov; 14(16):1457-71. PubMed ID: 9824324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
